KINIKSA

Serial Number 86765893
Registration 5566176
702

Registration Progress

Application Filed
Sep 23, 2015
Under Examination
Apr 11, 2017
Approved for Publication
Aug 16, 2016
Published for Opposition
Aug 16, 2016
Registered
Sep 18, 2018

Trademark Image

KINIKSA

Basic Information

Serial Number
86765893
Registration Number
5566176
Filing Date
September 23, 2015
Registration Date
September 18, 2018
Published for Opposition
August 16, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Jan 2, 2025
Registration
Registered
Classes
005

Rights Holder

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC.

83
Address
THIRD FLOOR, 23 OLD BOND STREET
LONDON W1S 4PZ
GB

Ownership History

Kiniksa Pharmaceuticals, Ltd.

Original Applicant
03
Hamilton HM 11 BM

Kiniksa Pharmaceuticals, Ltd.

Owner at Publication
03
Hamilton HM 11 BM

Kiniksa Pharmaceuticals, Ltd.

Original Registrant
03
Hamilton HM 11 BM

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC.

New Owner After Registration #1
83
LONDON GB

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
1001 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20180918)
Due Date
September 18, 2028
Grace Period Ends
March 18, 2029

Application History

37 events
Date Code Type Description Documents
Apr 11, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jan 2, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jan 2, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 2, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 2, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Sep 18, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 18, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 15, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 14, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 6, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 11, 2018 IUAF S USE AMENDMENT FILED Loading...
Aug 6, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 11, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 10, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 6, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 6, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 6, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 16, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 14, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 14, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 14, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 11, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 28, 2017 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Sep 13, 2016 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Aug 16, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 16, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 27, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 14, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 8, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 8, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 8, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 12, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 11, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 29, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 26, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
anti-inflammatories; cardiovascular pharmaceuticals; [ pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders; ] pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; [ pharmaceutical preparations for the prevention and treatment of pruritus; ] pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare diseases and disorders
First Use Anywhere: Nov 15, 2017
First Use in Commerce: Nov 15, 2017

Additional Information

Translation
The wording "KINIKSA" has no meaning in a foreign language.

Classification

International Classes
005